about
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action.Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor systemBuprenorphine: new treatment of opioid addiction in primary care.Prescribing to drug misusers in practice--often effective, but rarely straightforward.Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.Hepatitis infection in the treatment of opioid dependence and abuse.Naloxone treatment in opioid addiction: the risks and benefits.Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusersBuprenorphine rescue from naltrexone-induced opioid withdrawal during relatively rapid detoxification from high-dose methadone: a novel approachL-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroinBuprenorphine in the treatment of opiate dependence.Compliance with buprenorphine medication-assisted treatment and relapse to opioid use.Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatment.[Brazilian guideline for the treatment of patients with opioids dependence syndrome].Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence.
P2860
Q34320180-84197F31-73E0-442A-91D1-9515BF7A3526Q34411910-E1700F93-8417-44C3-8215-7FEF13840DF1Q34452695-2F96C8F5-98CD-4173-BE1F-F295CA1BE337Q34561447-3683F159-0546-4778-81AD-CEAA8369B55CQ34667890-CC20E61B-BF53-4A21-914C-E49A460A2CB0Q34749114-30BC6783-0D68-4906-B894-20BB194B91B2Q34764672-353FB1CA-0C99-4EEA-A1E6-B02DCC2D04EBQ35389163-7ABA8390-1248-4F2D-9A64-2CAEFB471192Q36762428-9CF87487-D65C-4F61-822D-035D142233D3Q36803326-E2E3FBF9-24DE-4FE9-A2FE-F5299A9075DCQ37285612-A16CAE10-3916-4B63-9EE3-A270291E1A1EQ37637054-39CB6EC2-4A2A-4D33-BA4C-CC92B9DB4D84Q38633387-E5A60606-17C8-49C9-81C4-A28AF9431A26Q42962930-93D06194-5E9C-45CE-A637-53350C9A1CA5Q44332334-F1E2D18A-5F5C-45A0-8496-5A8156724E23Q44334109-70B69275-03D6-4692-833C-C6E4CA494D2EQ45281477-5CDDD823-A7F1-4070-8ACD-0FC8B7AE812AQ46970878-5005AFC8-EEF8-4B91-B7DC-25320292278E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Buprenorphine and naloxone for heroin dependence.
@ast
Buprenorphine and naloxone for heroin dependence.
@en
Buprenorphine and naloxone for heroin dependence.
@nl
type
label
Buprenorphine and naloxone for heroin dependence.
@ast
Buprenorphine and naloxone for heroin dependence.
@en
Buprenorphine and naloxone for heroin dependence.
@nl
prefLabel
Buprenorphine and naloxone for heroin dependence.
@ast
Buprenorphine and naloxone for heroin dependence.
@en
Buprenorphine and naloxone for heroin dependence.
@nl
P2860
P1476
Buprenorphine and naloxone for heroin dependence.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11920-000-0012-8
P407
P577
2000-12-01T00:00:00Z
P6179
1041176611